Bajaj Healthcare Ltd
NSE:BAJAJHCARE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bajaj Healthcare Ltd
Net Income (Common)
Bajaj Healthcare Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bajaj Healthcare Ltd
NSE:BAJAJHCARE
|
Net Income (Common)
₹395m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Net Income (Common)
₹55.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
21%
|
CAGR 10-Years
11%
|
|
|
Cipla Ltd
NSE:CIPLA
|
Net Income (Common)
₹45.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Net Income (Common)
₹109.2B
|
CAGR 3-Years
37%
|
CAGR 5-Years
35%
|
CAGR 10-Years
11%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Net Income (Common)
₹46.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
32%
|
CAGR 10-Years
8%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Net Income (Common)
₹22.7B
|
CAGR 3-Years
40%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
Bajaj Healthcare Ltd
Glance View
Bajaj Healthcare Ltd. is a pharmaceutical company, which is engages in the development, manufacturing, and supply of amino acids, nutritional supplements, and active pharmaceutical ingredients. The company is headquartered in Thane, Maharashtra. The company went IPO on 2016-05-10. The firm is engaged in the manufacturing of bulk drugs and pharmaceutical products. The firm's segments include manufacturing of Bulk Drugs, and Formulation. The firm manufactures and markets Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and other Finished Dosage Forms (FDFs) catering to various therapeutic segments. The firm's product portfolio consists of various APIs in the therapeutic categories of Neutraceutical (Amino Acids), Vitamins, Anti-Convulsants, Bactericidal and Bacteriostatic, Diuretic and Vasodilator, Mineral and Nutritional supplements, Bronchodilater/Anti-asthmatic and Nootropics. Its FDFs include various therapeutic segments, such as Antibiotics, Anti-Arrhythmia, Anti-Convulsants, Anti-Diabetes, Anti-Platelets, Vitamins and its Derivatives and Anti-Hypertensive.
See Also
What is Bajaj Healthcare Ltd's Net Income (Common)?
Net Income (Common)
395m
INR
Based on the financial report for Mar 31, 2025, Bajaj Healthcare Ltd's Net Income (Common) amounts to 395m INR.
What is Bajaj Healthcare Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
9%
The average annual Net Income (Common) growth rates for Bajaj Healthcare Ltd have been -18% over the past three years , 9% over the past five years .
